[go: up one dir, main page]

NO954681D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO954681D0
NO954681D0 NO954681A NO954681A NO954681D0 NO 954681 D0 NO954681 D0 NO 954681D0 NO 954681 A NO954681 A NO 954681A NO 954681 A NO954681 A NO 954681A NO 954681 D0 NO954681 D0 NO 954681D0
Authority
NO
Norway
Prior art keywords
chemical connections
connections
chemical
Prior art date
Application number
NO954681A
Other languages
English (en)
Other versions
NO954681L (no
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO954681D0 publication Critical patent/NO954681D0/no
Publication of NO954681L publication Critical patent/NO954681L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO954681A 1993-05-21 1995-11-20 Kjemiske forbindelser NO954681L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
NO954681D0 true NO954681D0 (no) 1995-11-20
NO954681L NO954681L (no) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954681A NO954681L (no) 1993-05-21 1995-11-20 Kjemiske forbindelser

Country Status (19)

Country Link
EP (1) EP0699196A1 (no)
JP (1) JPH08510455A (no)
CN (1) CN1126473A (no)
AU (1) AU6928794A (no)
BG (1) BG100154A (no)
CA (1) CA2162921A1 (no)
CZ (1) CZ305195A3 (no)
FI (1) FI955587A0 (no)
GB (1) GB9310635D0 (no)
HU (1) HUT73790A (no)
IL (1) IL109703A0 (no)
NO (1) NO954681L (no)
OA (1) OA10195A (no)
PE (1) PE31195A1 (no)
PL (1) PL311702A1 (no)
SK (1) SK142495A3 (no)
TW (1) TW279866B (no)
WO (1) WO1994027989A1 (no)
ZA (1) ZA943494B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU679119B2 (en) * 1993-09-30 1997-06-19 Yamanouchi Pharmaceutical Co., Ltd. Azole derivative and pharmaceutical composition thereof
AU3846395A (en) * 1994-11-07 1996-05-31 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
EP0820989A4 (en) * 1995-03-01 1998-05-06 Yamanouchi Pharma Co Ltd IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION BASED ON SAID DERIVATIVES
AU6229698A (en) * 1997-02-21 1998-09-09 Takeda Chemical Industries Ltd. Fused ring compounds, process for producing the same and use thereof
AR034854A1 (es) 2000-11-17 2004-03-24 Takeda Chemical Industries Ltd Compuesto de imidazol condensado, prodroga del mismo, composición farmaceutica y agente para reducir androgenos que lo contienen ,metodo para producirlo, sal diastereomerica de dicho compuesto y metodo para producir un compuesto opticamente activo del compuesto
DE60144246D1 (de) 2000-11-20 2011-04-28 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
CA2431171A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
US7935722B2 (en) 2005-06-24 2011-05-03 Eli Lilly And Company Tetrahydrocarbazole derivatives useful as androgen receptor modulators
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
CN102803250B (zh) 2009-06-26 2014-04-16 诺华股份有限公司 作为cyp17的抑制剂的1,3-二取代的咪唑烷-2-酮衍生物
JP5964756B2 (ja) 2010-02-04 2016-08-03 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
MX342898B (es) 2010-05-12 2016-10-18 Radius Health Inc * Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
KR101926320B1 (ko) 2010-08-04 2018-12-06 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
JP2013537210A (ja) 2010-09-16 2013-09-30 ノバルティス アーゲー 17α−ヒドロキシラーゼ/C17,20−リアーゼ阻害剤
JP5965909B2 (ja) 2010-09-28 2016-08-10 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
WO2012149413A1 (en) 2011-04-28 2012-11-01 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
CA2902335C (en) 2013-03-14 2021-09-14 Pellficure Pharmaceuticals, Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
CA2943611A1 (en) 2014-03-28 2015-10-01 Duke University Method of treating cancer using selective estrogen receptor modulators
EP3191087A1 (en) 2014-09-12 2017-07-19 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
SG11201811225RA (en) 2016-06-22 2019-01-30 Radius Health Inc Ar+ breast cancer treatment methods
CA3044812A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione
JP7481115B2 (ja) 2017-01-05 2024-05-10 ラジウス ファーマシューティカルズ,インコーポレイテッド Rad1901-2hclの多形性形態

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
AU6928794A (en) 1994-12-20
HU9503321D0 (en) 1996-01-29
JPH08510455A (ja) 1996-11-05
BG100154A (en) 1996-07-31
OA10195A (en) 1996-12-18
FI955587A (fi) 1995-11-20
CN1126473A (zh) 1996-07-10
EP0699196A1 (en) 1996-03-06
NO954681L (no) 1995-11-20
SK142495A3 (en) 1996-06-05
PE31195A1 (es) 1995-10-18
WO1994027989A1 (en) 1994-12-08
ZA943494B (en) 1995-01-23
FI955587A0 (fi) 1995-11-20
CZ305195A3 (en) 1996-06-12
CA2162921A1 (en) 1994-12-08
IL109703A0 (en) 1994-08-26
GB9310635D0 (en) 1993-07-07
TW279866B (no) 1996-07-01
PL311702A1 (en) 1996-03-04
HUT73790A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO980154D0 (no) Kjemiske forbindelser
NO954681D0 (no) Kjemiske forbindelser
NO922113D0 (no) Kjemiske forbindelser
DE69400828D1 (de) Motor-Getriebe-Antriebsverbindung
ATA146094A (de) Windsichter
NO951433D0 (no) Kjemiske forbindelser
FI940356A (fi) Moppipuristin
NO980630D0 (no) Kjemiske forbindelser
ATA194593A (de) Sportschuh
ATA179094A (de) Kettenschloss
ATA212793A (de) Sportschuh
NO962264D0 (no) Kjemiske forbindelser
ATA135494A (de) Anschlussgarnitur
NO953697D0 (no) Kjemisk fremgangsmåte
NO954654D0 (no) Benzimiddazolyl-diazacyklo-oktanforbindelse
FI954400L (fi) Kemiallinen prosessi
NO921004D0 (no) Kjemiske forbindelser
KR950000463U (ko) 구급약품 케이스
DK85393D0 (da) Kemisk forbindelse
KR940026319U (ko) 에어 브렌더(Air-Blender)
NO964809D0 (no) Kjemiske forbindelser
ITRC930003A0 (it) Ecomat c
MX9200170A (es) Procedimiento quimico
FI670U1 (fi) Roekanordning
ATE144907T1 (de) Rollbrett